Aptevo Therapeutics Inc. Payments of Debt Issuance Costs
Aptevo Therapeutics Inc. (APVO) reported Payments of Debt Issuance Costs of $601.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2019-11-07
- Aptevo Therapeutics Inc. payments of debt issuance costs for the quarter ending 2017-09-30 was -$1.75M.
- Aptevo Therapeutics Inc. payments of debt issuance costs for the quarter ending 2017-06-30 was $0.00.
- Aptevo Therapeutics Inc. payments of debt issuance costs for the quarter ending 2017-03-31 was $1.90M.
- Aptevo Therapeutics Inc. payments of debt issuance costs for fiscal 2016 was $1.96M.
| Period end | Payments of Debt Issuance Costs 0 month | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2018-09-30 | $601.00K 10-Q · filed 2019-11-07 | ||||
| 2017-09-30 | -$1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$1.75M derived: sum of 2 quarters · filed 2018-11-14 | $150.00K 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $1.90M 10-Q · filed 2017-08-10 | |||
| 2017-03-31 | $1.90M 10-Q · filed 2017-05-12 | ||||
| 2016-12-31 | $1.96M 10-K · filed 2017-03-31 | ||||
| 2016-08-04 | $1.90M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |